Purchase Order 75N93019P00165

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for $146,750 on November 6, 2018. The order is for TURBO293 Transfection Reagent for HEK293 cells, a proprietary biological research product. Speed Biosystems is a minority-owned, small disadvantaged business based in Rockville, Maryland. Work is performed in Potomac, Maryland, with an ultimate completion date of November 20, 2018. The pricing is firm fixed price under a pre-solicitation...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for $29,710 on January 22, 2019, for TURBO293 Transfection Reagent (20 mL). Speed Biosystems is a minority-owned small disadvantaged business. Performance occurs in Potomac, Maryland. The order carries a firm fixed price and concludes on March 4, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for TURBO293 Transfection Reagent with a ceiling value of $683,400 on April 9, 2019. Speed Biosystems is a minority-owned, small disadvantaged business. Performance is located in Germantown, Maryland, with an ultimate completion date of April 8, 2020. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for $20,402.00 on November 25, 2019, under the Total Small Business set-aside. The order procures TURBO293 Transfection Reagent (20L, catalog number PXX1006) with performance in Potomac, Maryland. Speed Biosystems is a minority-owned, small disadvantaged business. The purchase order is firm fixed price with an ultimate completion date of November 19, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for TURBO293 transfection reagent (20 mL, catalog PXX1002) valued at $146,750 on November 30, 2020. Speed Biosystems is a minority-owned small disadvantaged business. Place of performance is Potomac, Maryland. The order is firm fixed price with an ultimate completion date of December 30, 2020. No small business set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Speed Biosystems, LLC for $146,600 on November 29, 2017. Speed Biosystems is a minority-owned small disadvantaged business. Performance occurs in Bethesda, Maryland. The order is for TURBO293 Transfection Reagents to support coronavirus and vaccine development research. The contract carries a firm fixed price and concludes January 2, 2018.</p>

This is a $248,980 firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The contract is for the supply of Speed Biosystems' proprietary TURBO293 Transfection Reagent, which is a critical product supporting coronavirus-related research, vaccine production, and the development of immunogens and...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC for the provision of COVID-19 TURBO 293 transfection reagents. The contract, valued at $148,325.00, has a period of performance through June 8, 2023. Speed Biosystems is a minority-owned, small disadvantaged business that has previously received over $3 million in prime federal contracts...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents to support coronavirus-related research. The contract, valued at $148,325.00, does not have a set-aside designation. Speed Biosystems has received over $3 million in prime federal contracts from...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Speed Biosystems, LLC, a minority-owned and small disadvantaged business. The $99,345.00 firm-fixed price purchase order is for the supply of 500 units of Speed Biosystems' proprietary TURBO293 Transfection Reagent, a key product used in coronavirus-related research, vaccine production, and the development of immunogens...